Viewing Study NCT06081595


Ignite Creation Date: 2025-12-24 @ 2:07 PM
Ignite Modification Date: 2025-12-27 @ 10:39 PM
Study NCT ID: NCT06081595
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-10-13
First Post: 2023-10-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment
Sponsor: Jin Li
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module